XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance at Dec. 31, 2019 $ (25,665)   $ 2 $ 699 $ (26,366)
Beginning balance, shares at Dec. 31, 2019   6,712,085      
Beginning balance at Dec. 31, 2019   $ 30,960      
Beginning balance, Shares at Dec. 31, 2019     2,257,740    
Issuance of common stock upon exercise of stock options, shares 0        
Issuance of Series B redeemable convertible preferred stock, net of issuance cost   $ 17,466      
Issuance of Series B redeemable convertible preferred stock, net of issuance cost, shares   3,754,084      
Stock-based compensation $ 58     58  
Net loss (1,727)       (1,727)
Ending balance at Mar. 31, 2020 (27,334)   $ 2 757 (28,093)
Ending balance, Shares at Mar. 31, 2020   10,466,169      
Ending balance at Mar. 31, 2020   $ 48,426      
Ending balance, Shares at Mar. 31, 2020     2,257,740    
Beginning balance at Dec. 31, 2020 $ (62,308) [1]   $ 3 1,403 (63,714)
Beginning balance, shares at Dec. 31, 2020 23,978,747 [1] 23,978,747      
Beginning balance at Dec. 31, 2020 $ 121,080 [1] $ 121,080      
Beginning balance, Shares at Dec. 31, 2020     2,712,694    
Conversion of redeemable convertible preferred shares into common stock 121,080   $ 24 121,056  
Conversion of redeemable convertible preferred shares into common stock, shares   (23,978,747)      
Conversion of redeemable convertible preferred shares into common stock   $ (121,080)      
Conversion of redeemable convertible preferred shares into common stock, shares     23,978,747    
Conversion of convertible notes into common stock 24,982   $ 2 24,980  
Conversion of convertible notes into common stock, shares     1,470,947    
Issuance of common stock upon IPO, net of issuance costs 159,899   $ 10 159,889  
Issuance of common stock upon IPO, net of issuance costs, shares     10,350,000    
Issuance of common stock upon exercise of stock options $ 48     48  
Issuance of common stock upon exercise of stock options, shares 37,760   37,760    
Stock-based compensation $ 527     527  
Stock-based compensation, shares     0    
Net loss (13,316)       (13,316)
Ending balance at Mar. 31, 2021 $ 230,912   $ 39 $ 307,903 $ (77,030)
Ending balance, Shares at Mar. 31, 2021 0        
Ending balance, Shares at Mar. 31, 2021     38,550,148    
[1] The balance sheet as of December 31, 2020 is derived from the audited financial statements as of that date